Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexicon Pharmaceuticals Inc. logo

Director Sullivan Diane E. converted options into 36,810 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LXRX· Lexicon Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LXRX (Lexicon Pharmaceuticals Inc.) and more on Quantisnow.